08:00 , Nov 24, 2014 |  BC Week In Review  |  Clinical News

BreathID: Pivotal trial started

Exalenz began an international pivotal trial to compare BreathID vs. the use of HVPG in at least 200 patients with chronic liver disease. Exalenz Bioscience Ltd. (Tel Aviv:EXEN), Modiin, Israel   Product: BreathID   Business:...
07:00 , Jul 22, 2013 |  BC Week In Review  |  Company News

Exalenz sales and marketing update

Exalenz launched the BreathID Hp test worldwide to detect Helicobacter pylori. The real-time carbon-13 dioxide (13CO2) breath test runs on Exalenz's BreathID system, which has CE Mark approval in the EU and 510(k) clearance from...